메뉴 건너뛰기
Clinical Prostate Cancer
Volumn 2, Issue 1, 2003, Pages 13-14
High androgen receptor levels are predictive of decreased survival in prostate cancer
[No Author Info available]
Author keywords

[No Author keywords available]
Indexed keywords

ANDROGEN RECEPTOR; PROSTATE SPECIFIC ANTIGEN;
EID: 0042510398     PISSN: 15400352     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1540-0352(11)70012-9     Document Type: Article
Times cited : (16)
References (9)
  • 1
    • 0035496220 scopus 로고    scopus 로고
    • The development of androgen-independent prostate cancer
    • Feldman BJ, Feldman D. The development of androgen-independent prostate cancer. Nat Rev Cancer 2001; 1:34-45.
    • (2001) Nat Rev Cancer , vol.1 , pp. 34-45
    • Feldman, B.J.1    Feldman, D.2
  • 2
    • 0036755404 scopus 로고    scopus 로고
    • Androgen receptor as a target in androgen-independent prostate cancer
    • Balk SF. Androgen receptor as a target in androgen-independent prostate cancer. Urology 2002; 60:132-138.
    • (2002) Urology , vol.60 , pp. 132-138
    • Balk, S.F.1
  • 3
    • 0035930133 scopus 로고    scopus 로고
    • Androgen receptor signaling in androgen-refractory prostate cancer
    • Grossmann ME, Huang H, Tindall DJ. Androgen receptor signaling in androgen-refractory prostate cancer. J Natl Cancer Inst 2001; 93:1687-1697.
    • (2001) J Natl Cancer Inst , vol.93 , pp. 1687-1697
    • Grossmann, M.E.1    Huang, H.2    Tindall, D.J.3
  • 4
    • 0036170838 scopus 로고    scopus 로고
    • Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells
    • Zegarra-Moro OL, Schmidt LJ, Huang H, et al. Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells. Cancer Res 2002; 62:1008-1013.
    • (2002) Cancer Res , vol.62 , pp. 1008-1013
    • Zegarra-Moro, O.L.1    Schmidt, L.J.2    Huang, H.3
  • 5
    • 0029080807 scopus 로고
    • Immunostaining for prostate cancer androgen receptor in paraffin identifies a subset of men with a poor prognosis
    • Pertschuk LP, Schaeffer H, Feldman JG, et al. Immunostaining for prostate cancer androgen receptor in paraffin identifies a subset of men with a poor prognosis. Lab Invest 1995; 73:302-305.
    • (1995) Lab Invest , vol.73 , pp. 302-305
    • Pertschuk, L.P.1    Schaeffer, H.2    Feldman, J.G.3
  • 6
    • 0030063211 scopus 로고    scopus 로고
    • Androgen receptor content of prostate carcinoma cells estimated by immunohistochemistry is related to prognosis of patients with stage D2 prostate carcinoma
    • Takeda H, Akakura K, Masai M, et al. Androgen receptor content of prostate carcinoma cells estimated by immunohistochemistry is related to prognosis of patients with stage D2 prostate carcinoma. Cancer 1996; 77:934-940.
    • (1996) Cancer , vol.77 , pp. 934-940
    • Takeda, H.1    Akakura, K.2    Masai, M.3
  • 7
    • 0025819482 scopus 로고
    • Immunohistochemical study of androgen receptors in metastatic prostate cancer. Comparison of receptor content and response to hormonal therapy
    • Sadi MV, Walsh PC, Barrack ER. Immunohistochemical study of androgen receptors in metastatic prostate cancer. Comparison of receptor content and response to hormonal therapy. Cancer 1991; 67:3057-3064.
    • (1991) Cancer , vol.67 , pp. 3057-3064
    • Sadi, M.V.1    Walsh, P.C.2    Barrack, E.R.3
  • 8
    • 0032862731 scopus 로고    scopus 로고
    • Androgen receptor expression in prostate cancer lymph node metastases is predictive of outcome after surgery
    • Sweat SD, Pacelli A, Bergstralh EJ, et al. Androgen receptor expression in prostate cancer lymph node metastases is predictive of outcome after surgery. J Urol 1999; 161:1233-1237.
    • (1999) J Urol , vol.161 , pp. 1233-1237
    • Sweat, S.D.1    Pacelli, A.2    Bergstralh, E.J.3
  • 9
    • 85009046037 scopus 로고    scopus 로고
    • High levels of androgen receptor in PCA is associated with aggressive disease and is an independent predictor of survival
    • Abstract #307
    • Ayala G, Li R, Weigel N, et al. High levels of androgen receptor in PCA is associated with aggressive disease and is an independent predictor of survival. J Urol 2003; 169(suppl 4):79 (Abstract #307).
    • (2003) J Urol , vol.169 , Issue.SUPPL. 4 , pp. 79
    • Ayala, G.1    Li, R.2    Weigel, N.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.